COMMUNIQUÉS West-GlobeNewswire

Aleafia to Release Q3 Results on Nov 26, Hold First Ever Results Call
12/11/2018
TORONTO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. ( TSXV: ALEF; OTCQX: ALEAF, FRA: ARAH ) (“ Aleafia “) or (the “ Company “), a highly differentiated cannabis company with major cannabis cultivation and [...]
Transactions under Novozymes’ stock buyback program
12/11/2018
Please read the full announcement in the attached PDF Attachment 2018_63_Stock_Buybackprogram_EN
Apotheca Biosciences (PCFP) Plans Uplisting to OTCQB
12/11/2018
SAINT PETERSBURG, FL, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Apotheca Biosciences (OTC PINK: PCFP), a developer of cutting-edge medical products, nutraceuticals, drug formulations and cannabis delivery [...]
Pain Therapeutics Appeals FDA Decision on REMOXY
12/11/2018
AUSTIN, Texas, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Pain Therapeutics, Inc. (Nasdaq: PTIE), a biopharmaceutical company, today announced that it has petitioned the Food & Drug Administration (FDA) regarding a Complete [...]
MyoKardia Presents Preclinical Evidence of Mavacamten’s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions
12/11/2018
Improved Left Ventricular Compliance Demonstrated in Genetic Pig Model of Non-Obstructed Hypertrophic Cardiomyopathy Results Add to Growing Body of Evidence of Mavacamten’s Dual Activity in Increasing Compliance and [...]
New Findings from Pluristem’s Phase II IC study: PLX-PAD Cells Significantly Improves Blood Glucose Control (HbA1c) and Reduce Chronic Inflammation
12/11/2018
Additional data from Pluristem’s Phase II IC study were presented at the 2018 American Heart Association Scientific Sessions HAIFA, Israel, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) ( [...]
Auxly Reports Q3 2018 Financial Results and Highlights Key Milestones
12/11/2018
VANCOUVER, British Columbia, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") has reported its financial and operational results for the three and [...]
Collegium to Present at Upcoming Investor Conferences
12/11/2018
STOUGHTON, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a specialty pharmaceutical company focused on becoming the leader in responsible pain management by developing and [...]
Aptinyx Exploratory Clinical Studies Provide First Evidence that NYX-2925 Elicits Rapid, Persistent, NMDAr-Mediated Pharmacodynamic Activity in Humans
12/11/2018
Studies in Healthy Human Volunteers Reinforce Mechanism of Action Observed in Preclinical Studies EVANSTON, Ill., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company [...]
Myriad to Present New Data from Its Industry-Leading Portfolio of Genetic Tests for Breast Cancer at the 2018 San Antonio Breast Cancer Symposium
12/11/2018
SALT LAKE CITY, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized medicine, today announced that 10 studies will be featured at the San Antonio Breast Cancer [...]
Assembly Biosciences Presents Final Results of Phase 1b Study of ABI-H0731 at 2018 AASLD
12/11/2018
First Presentation of HBV RNA Reduction Data, a Distinguishing Feature of Core Inhibitors SAN FRANCISCO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ: ASMB), a clinical-stage biotechnology [...]
Zealand Pharma to attend Jefferies and Bryan, Garnier & Co Healthcare Conferences
12/11/2018
Press release - No. 23 / 2018 Zealand Pharma to attend Jefferies and Bryan, Garnier & Co Healthcare Conferences Copenhagen, November 12, 2018 - Britt Meelby Jensen, President and Chief Executive Officer of Zealand [...]
Enzymatica AB: Prospectus for Enzymatica's rights issue with preferential rights for existing shareholders published
12/11/2018
Press release November 12, 2018 NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONGKONG, JAPAN, CANADA, SWITZERLAND, SINGAPORE, SOUTH AFRICA OR NEW ZEELAND OR ANY OTHER [...]
Ziopharm Oncology to Host Conference Call Today at 8 a.m.
12/11/2018
BOSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq: ZIOP), today will host a webcast and conference call today, Nov. 12, at 8 a.m. ET. On the call, management will discuss recent corporate [...]
EyePoint Pharmaceuticals Announces Assignment of Permanent J-Code for DEXYCU™ by the Center for Medicare and Medicaid Services (CMS)
12/11/2018
WATERTOWN, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness Week
12/11/2018
Summit Therapeutics plc (‘Summit’ or the ’Company’) Summit Highlights Importance of Innovation in Fight Against Antibiotic Resistance During Antibiotics Awareness Week Preclinical Data on New Mechanism Antibiotic SMT- [...]
Capricor to Meet with FDA under its RMAT Designation to Discuss HOPE-2 Clinical Trial
12/11/2018
Focus will be on Milestones for Development and Commercialization CAP-1002 Therapy for Duchenne Muscular Dystrophy LOS ANGELES, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR) announced today that [...]
Ziopharm Oncology Announces Immuno-oncology Clinical Supply Agreement with Regeneron to Evaluate Combination Therapy for Patients with Brain Cancer
12/11/2018
BOSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. , (Nasdaq:ZIOP) today announced a clinical supply agreement with Regeneron Pharmaceuticals, Inc. to evaluate Ziopharm’s Ad-RTS-hIL-12 plus veledimex in [...]
Bioxytran Inc’s New Compound for Treating Strokes Will be the Company’s New Health Mission Moving Forward
12/11/2018
Company Formerly Known as U.S. Rare Earth Minerals, Inc. Focusing on First-In-Class Ischemic Stroke Treatment BOSTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- U.S. Rare Earth Minerals, Inc. today announced that it has changed [...]

Pages